✦ LIBER ✦

Levetiracetam: Part II, the Clinical Profile of a Novel Anticonvulsant Drug

✍ Scribed by Tim De Smedt; Robrecht Raedt; Kristl Vonck; Paul Boon

Book ID: 109105718
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 125 KB
Volume: 13
Category: Article
ISSN: 1080-563X
DOI: 10.1111/j.1527-3458.2007.00005.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levetiracetam: The Profile of a Novel An

Levetiracetam: The Profile of a Novel Anticonvulsant Drug—Part I: Preclinical Data

✍ Tim De Smedt; Robrecht Raedt; Kristl Vonck; Paul Boon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Levetiracetam: The Preclinical Profile o

Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs?

✍ Henrik Klitgaard 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 345 KB

A systematic review of the safety profil

A systematic review of the safety profile of levetiracetam: a new antiepileptic drug

✍ Jacqueline French; Pascal Edrich; Joyce A Cramer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 110 KB

An epidemiological study of the clinical

An epidemiological study of the clinical impact of pharmacokinetic anticonvulsant drug interactions based on serum drug level analysis

✍ F. Pisani; A. Fazio; C. Artesi; G. Oteri; B. Pisani; F. Romano; E. Perucca; R. D 📂 Article 📅 1987 🏛 Springer Milan 🌐 English ⚖ 513 KB

Synthesis, characterization, and oxidase

Synthesis, characterization, and oxidase activities of copper(II) complexes of the anticonvulsant drug valproate

✍ A Latif Abuhijleh; Clifton Woods 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 789 KB

Development of clinical dosage forms for

Development of clinical dosage forms for a poorly water-soluble drug II: Formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug

✍ Ping Li; Sara R. Hynes; Thomas F. Haefele; Madhu Pudipeddi; Alan E. Royce; Abu T 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 706 KB

The solution of a poorly water-soluble drug in a liquid lipid-surfactant mixture, which served as a microemulsion preconcentrate, was converted into a solid form by incorporating it in a solid polyethylene glycol (PEG) matrix. The solid microemulsion preconcentrates thus formed consisted of Capmul P